China's anti-corruption push continues
A British man and his American wife will face court in China next month in connection with bribery allegations involving the pharmaceutical giant GlaxoSmithKline.
The development makes up part of a broader anti-corruption push in China.
But how transparent are the processes involved in the anti-graft campaign and how will it affect other multinationals?
Hans Hendrischke, director of the China Studies Centre at The University of Sydney, says the Mainland's anti-corruption drive is simply a regular rotation of government processes which, in the end, will favour multinationals.